Mu J Q, Mi B Y, Ding X Y, Chen B H, Hua X
Tianjin University Aier Eye Institute, Eye Hospital, Tianjin 300190, China.
Aier School of Ophthalmology, Central South University, Changsha 410125, China.
Zhonghua Yan Ke Za Zhi. 2024 Feb 11;60(2):186-192. doi: 10.3760/cma.j.cn112142-20231020-00160.
Corneal diseases are prevalent eye conditions in China, and the lack of effective treatment in the short term can lead to blindness. However, delivering drugs to the cornea safely and effectively poses a significant challenge due to the presence of ocular barriers and clearance mechanisms. Conventional drug delivery methods exhibit low bioavailability, making it difficult to achieve therapeutic effects. Microneedles, with their ability to penetrate ocular surface barriers effectively, offer a low-invasive and highly promising drug delivery technology. This article introduces the main delivery barriers on the ocular surface, classifies microneedles, and highlights the latest developments in the treatment of corneal diseases. Finally, the potential challenges of applying microneedle delivery systems to the ocular surface are analyzed, aiming to provide insights for the clinical application of microneedles in corneal diseases.
角膜疾病在中国是常见的眼部疾病,短期内缺乏有效的治疗可能导致失明。然而,由于眼部屏障和清除机制的存在,安全有效地将药物递送至角膜面临重大挑战。传统的药物递送方法生物利用度低,难以达到治疗效果。微针能够有效穿透眼表屏障,提供了一种低侵入性且极具前景的药物递送技术。本文介绍了眼表的主要递送屏障,对微针进行了分类,并重点阐述了角膜疾病治疗的最新进展。最后,分析了将微针递送系统应用于眼表的潜在挑战,旨在为微针在角膜疾病中的临床应用提供见解。